N4-hydroxycytidine
A nucleoside analogue that is cytidine which carries a hydroxy group at the N4-positon. It has broad-spectrum antiviral activity against influenza, SARS-CoV , SARS-CoV-2 and MERS-CoV.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
Chemical structure
| Molecular formula | C9H13N3O6 |
|---|---|
| Charge | 0 |
| Average mass | 259.218 Da |
| Monoisotopic mass | 259.08044 Da |
| Source | ChEBI |
| InChIKey | XCUAIINAJCDIPM-XVFCMESISA-N |
O=c1nc(=NO)ccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1
Also called
- N-hydroxy-3,4-dihydrocytidine
- 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one
- 4-N-hydroxycytidine
- 4-oxime uridine
- EIDD 1931
- EIDD-1931
- N(4)-hydroxycytidine
- N-hydroxycytidine
- NHC
- β-D-N4-hydroxycytidine
Cross-references
Drug registries
Activity roles
- anticoronaviral agent
CHEBI:149553 - antiviral agent
CHEBI:22587
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:180654 |
N4-hydroxycytidine | antibioticmech:chebi-82bc2fb6e2 |
2026-08-30 |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories